MedX Health Corp
MDXHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $135 | $89 | $111 | $188 |
| % Growth | 52.8% | -20.3% | -40.9% | – |
| Cost of Goods Sold | $98 | $71 | $63 | $115 |
| Gross Profit | $37 | $18 | $48 | $73 |
| % Margin | 27.5% | 19.9% | 42.9% | 38.9% |
| R&D Expenses | $125 | $126 | $124 | $133 |
| G&A Expenses | $686 | $757 | $1,041 | $212 |
| SG&A Expenses | $686 | $824 | $1,041 | $214 |
| Sales & Mktg Exp. | $0 | $8 | $0 | $2 |
| Other Operating Expenses | $105 | $0 | $84 | $56 |
| Operating Expenses | $916 | $949 | $1,249 | $403 |
| Operating Income | -$879 | -$932 | -$1,201 | -$330 |
| % Margin | -649.6% | -1,052.8% | -1,081.1% | -175.5% |
| Other Income/Exp. Net | -$405 | -$384 | -$396 | -$776 |
| Pre-Tax Income | -$1,284 | -$1,316 | -$1,597 | -$1,106 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,284 | -$1,316 | -$1,597 | -$1,106 |
| % Margin | -948.9% | -1,486.6% | -1,437.5% | -588.1% |
| EPS | -0.004 | -0.005 | -0.006 | -0.004 |
| % Growth | 4.4% | 23.7% | -43.9% | – |
| EPS Diluted | -0.004 | -0.005 | -0.006 | -0.004 |
| Weighted Avg Shares Out | 301,792 | 290,788 | 272,314 | 266,720 |
| Weighted Avg Shares Out Dil | 301,792 | 290,786 | 272,314 | 266,720 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $405 | $384 | $396 | $776 |
| Depreciation & Amortization | $13 | $11 | $11 | $12 |
| EBITDA | -$866 | -$920 | -$1,190 | -$318 |
| % Margin | -640.1% | -1,039.9% | -1,070.8% | -169.3% |